Form D — Stork Therapeutics, Inc.
0002059988-25-000001 · filed 2025-05-08
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,725,000
- Total sold
- $1,345,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Stork Therapeutics, Inc.
- CIK
- 2059988
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 325 15TH AVENUE
SAN FRANCISCO, CA 94118 - Phone
- (415) 699-7583
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gregg Fine · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Brendan Kennedy · DirectorSan Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.